David Scott Tomsche

CIK: 0001384044

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ICCC

IMMUCELL CORP /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ICCC
IMMUCELL CORP /DE/
Apr 15, 2026
Award(A)
Non Qualified Stock Options (Right to buy)
Direct
11.9K shares-
ICCC
IMMUCELL CORP /DE/
Nov 25, 2025
Purchase(P)
Direct
1.6K shares at avg. $4.76$8K
ICCC
IMMUCELL CORP /DE/
Nov 25, 2025
Purchase(P)
Indirect
1.6K shares at avg. $4.76$8K
ICCC
IMMUCELL CORP /DE/
Apr 16, 2025
Award(A)
Non Qualified Stock Options (Right to buy)
Direct
10K shares-
ICCC
IMMUCELL CORP /DE/
Sep 20, 2024
Award(A)
Non Qualified Stock Options (Right to buy)
Direct
10K shares at avg. $3.60-

		Type	Shares	Price		Ownership
Apr 15, 2026	ICCC IMMUCELL CORP /DE/	Award(A) Non Qualified Stock Options (Right to buy)	11,933	-	-	Direct
Nov 25, 2025	ICCC IMMUCELL CORP /DE/	Purchase(P)	1,633	$4.76	$7,773	Direct
Nov 25, 2025	ICCC IMMUCELL CORP /DE/	Purchase(P)	1,633	$4.76	$7,781	Indirect
Apr 16, 2025	ICCC IMMUCELL CORP /DE/	Award(A) Non Qualified Stock Options (Right to buy)	10,000	-	-	Direct
Sep 20, 2024	ICCC IMMUCELL CORP /DE/	Award(A) Non Qualified Stock Options (Right to buy)	10,000	$3.60	-	Direct

1-5 of 5 transactions

About Tomsche David Scott

Tomsche David Scott (SEC CIK 0001384044) files insider reports with the SEC as Director of IMMUCELL CORP /DE/ (ICCC).

Signal8 holds 4 ownership filings by Tomsche David Scott, all Form 4s, filed between Sep 24, 2024 and Apr 16, 2026. Those filings report 5 transactions, from Sep 20, 2024 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tomsche David Scott's filings is in PORTLAND, ME.

Recent filings by Tomsche David Scott

Apr 15, 2026: Grant or award of ICCC derivative securities (Form 4, code A).
Nov 25, 2025: Open-market purchases of ICCC shares (2 lines, Form 4, code P).
Apr 16, 2025: Grant or award of ICCC derivative securities (Form 4, code A).
Sep 20, 2024: Grant or award of ICCC derivative securities (Form 4, code A).

Other insiders filing for IMMUCELL CORP /DE/ (ICCC)

te Boekhorst Paul Francis Olivier, President and CEO
DiMarco Anthony, Director
Guillemette Gilles, Director
Turner Kathy V, Director
Basse Gloria F, Director
Wainman Paul R, Director

How to read Form 4 transaction codes